Mäyränpää Mikko I, Heikkilä Hanna M, Lindstedt Ken A, Walls Andrew F, Kovanen Petri T
Wihuri Research Institute, University of Helsinki, Helsinki, Finland.
Coron Artery Dis. 2006 Nov;17(7):611-21. doi: 10.1097/01.mca.0000224420.67304.4d.
Endothelial erosion has emerged as an important contributor to the pathogenesis of atherosclerosis and its complications, but the molecular mechanisms have remained unclear. As activated mast cells capable of secreting neutral proteases are present in the intima of eroded coronary plaques, we investigated their potential roles in endothelial erosion.
Studies involving double immunostaining of mast cells (tryptase(pos) cells) and platelets (CD42b) in human coronary artery specimens indicated that the number of subendothelial mast cells correlated with the number of parietal microthrombi (P=0.001, rs 0.27). The number of parietal microthrombi was significantly higher (P<0.001) in areas of plaques than in areas of healthy intima. Of the microthrombi 86% were in the lesional coronary segments, of all subendothelial mast cells 15% were located under parietal microthrombi, and of all parietal microthrombi 49% were located over subendothelial mast cells. Double immunostaining revealed the mast cell to neutrophil ratio in the human coronary artery intima to be 5 : 1, and that mast cells are a major local source of cathepsin G. Scanning electron and light microscopy indicated that treatment of fresh human coronary arteries intraluminally with recombinant human (rh)-tryptase and rh-chymase induced endothelial damage characterized by retraction of endothelial cells, disruption of endothelial cell to cell adhesions and desquamation of endothelial cells. VE-cadherin and fibronectin, which are necessary for cell-cell interactions and endothelial cell adhesion, were degraded by tryptase and chymase and also by cathepsin G.
Activated subendothelial mast cells may contribute to endothelial erosion by releasing proteases capable of degrading VE-cadherin and fibronectin.
内皮糜烂已成为动脉粥样硬化及其并发症发病机制的重要促成因素,但其分子机制仍不清楚。由于在糜烂的冠状动脉斑块内膜中存在能够分泌中性蛋白酶的活化肥大细胞,我们研究了它们在内皮糜烂中的潜在作用。
对人冠状动脉标本中的肥大细胞(类胰蛋白酶阳性细胞)和血小板(CD42b)进行双重免疫染色的研究表明,内皮下肥大细胞的数量与壁层微血栓的数量相关(P = 0.001,rs 0.27)。斑块区域的壁层微血栓数量明显高于健康内膜区域(P < 0.001)。在微血栓中,86%位于病变冠状动脉节段,在所有内皮下肥大细胞中,15%位于壁层微血栓下方,在所有壁层微血栓中,49%位于内皮下肥大细胞上方。双重免疫染色显示,人冠状动脉内膜中肥大细胞与中性粒细胞的比例为5:1,并且肥大细胞是组织蛋白酶G的主要局部来源。扫描电子显微镜和光学显微镜检查表明,用重组人(rh)-类胰蛋白酶和rh-糜蛋白酶对新鲜人冠状动脉进行腔内处理可诱导内皮损伤,其特征为内皮细胞回缩、内皮细胞间黏附破坏以及内皮细胞剥脱。细胞间相互作用和内皮细胞黏附所必需的血管内皮钙黏蛋白和纤连蛋白被类胰蛋白酶、糜蛋白酶以及组织蛋白酶G降解。
活化的内皮下肥大细胞可能通过释放能够降解血管内皮钙黏蛋白和纤连蛋白的蛋白酶而导致内皮糜烂。